Search

Your search keyword '"Lawlor, Rita Teresa"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Lawlor, Rita Teresa" Remove constraint Author: "Lawlor, Rita Teresa"
28 results on '"Lawlor, Rita Teresa"'

Search Results

2. MCL1 as putative target in pancreatoblastoma

3. Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC

4. Gα15 in early onset of pancreatic ductal adenocarcinoma

6. ecDNA amplification of MYC drives intratumor copy-number heterogeneity and adaptation to stress in PDAC

7. CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer

8. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

9. The role of CXCR1/2 dual inhibitor ladarixin on tumor burden and immunotherapy response in pancreatic cancer.

10. Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer

11. Additional file 2 of IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation

12. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

14. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases

15. Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo

16. MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages

18. Of mice and men: parallel analysis of pancreatic cancer tumours and patient-derived mouse models by next-generation sequencing

19. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

22. SLC22A3 polymorphisms may influence overall patient survival- PANDORA study

23. 1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS

24. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling

25. Biosampling and biobanking (Chapter7)

26. 483 The Concept of Perihilar Cholangiocarcinoma Is Still Valid? Analysis of Clinicopathological Features and Mutational Genes Profiling in a Series of 56 Cases

27. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival

28. Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer

Catalog

Books, media, physical & digital resources